Skandinaviska Enskilda Banken (SEB)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-256,200
| Closed | -$2.87M | – | 745 |
|
|
2017
Q3 | $2.87M | Hold |
256,200
| – | – | 0.03% | 390 |
|
|
2017
Q2 | $2.82M | Buy |
256,200
+7,700
| +3% | +$84.7K | 0.03% | 397 |
|
|
2017
Q1 | $2.44M | Buy |
248,500
+91,700
| +58% | +$899K | 0.02% | 404 |
|
|
2016
Q4 | $1.69M | Buy |
156,800
+20,900
| +15% | +$226K | 0.02% | 401 |
|
|
2016
Q3 | $1.39M | Sell |
135,900
-130,400
| -49% | -$1.34M | 0.02% | 548 |
|
|
2016
Q2 | $3.48M | Sell |
266,300
-143,400
| -35% | -$1.87M | 0.04% | 322 |
|
|
2016
Q1 | $4.51M | Sell |
409,700
-293,200
| -42% | -$3.23M | 0.05% | 259 |
|
|
2015
Q4 | $6.47M | Buy |
+702,900
| New | +$6.47M | 0.08% | 183 |
|